📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
JG Chemicals Reports Record Q3 FY26 Performance; Revenue Up 19% YoY to ₹249 Crores
J.G. Chemicals achieved its highest-ever quarterly revenue, EBITDA, and PAT in Q3 FY26, with consolidated revenue reaching ₹249 crores, a 19% YoY increase. The company is progressing with its Dahej greenfield project, targeting Phase 1 commissioning in H1 FY27, alongside brownfield expansion at Naidupeta. Management highlighted strong demand from the tire industry, supported by a ₹12,000 crore sector-wide capex plan and recent GST reductions. Additionally, pilot trials for a new recycled rubber project have shown encouraging results, potentially diversifying the product portfolio.
Key Highlights
Reported highest-ever quarterly consolidated revenue of ₹249 crores, up 19% YoY.
Q3 FY26 EBITDA stood at ₹26 crores with a PAT of approximately ₹18 crores.
Greenfield project at Dahej, Gujarat, is on track for Phase 1 commissioning in H1 FY27.
Tire industry demand remains robust, supported by ₹12,000 crore capex plans from major manufacturers.
Commenced pilot-scale trials for a specialized recycled rubber project to increase content per tire.
💼 Action for Investors
Investors should monitor the timely commissioning of the Dahej plant in H1 FY27 as it will be a key volume driver. The company's entry into recycled rubber and focus on non-rubber segments provide a positive outlook for margin improvement.
JG Chemicals Q3 FY26: Highest-Ever Quarterly Sales; Revenue at ₹248.5 Cr with 10.4% EBITDA Margin
J.G. Chemicals reported its highest-ever quarterly sales in Q3 FY26, with revenue reaching ₹248.5 crore and a PAT of ₹18.4 crore. The company maintained strong margins with an EBITDA of ₹25.9 crore (10.42% margin) driven by better capacity utilization and a higher mix of specialty orders. For the nine-month period (9M-FY26), revenue stood at ₹686.8 crore with an EPS of ₹12.20. Growth is supported by a ₹100 crore self-funded expansion in Dahej, expected to commission in H1-FY27 with a ₹900 crore revenue potential.
Key Highlights
Achieved highest-ever quarterly sales in Q3 FY26 with revenue of ₹248.5 crore and PAT of ₹18.4 crore
EBITDA margins improved to 10.42% in Q3, supported by operating leverage and specialty order mix
Investing ₹100 crore via internal accruals for a new 40,000 MTPA Dahej facility, targeting ₹900 crore in potential revenue
Strategic shift to increase non-rubber segment revenue from 15% to 30% over the next few years
Dominant market position with ~30% share in India and serving 9 out of the top 10 global tyre manufacturers
💼 Action for Investors
Investors should monitor the timely commissioning of the Dahej plant in H1-FY27, which is a significant growth driver. The company's ability to maintain double-digit EBITDA margins while diversifying into non-rubber segments makes it a strong play in the specialty chemicals and recycling space.
J.G. Chemicals Q3 FY26 Standalone Revenue Grows 16.7% YoY to ₹704.63 Million
J.G. Chemicals reported a standalone revenue of ₹704.63 million for Q3 FY26, a 16.7% increase compared to ₹603.71 million in Q3 FY25. Net profit for the quarter rose slightly by 6.2% YoY to ₹37.56 million, although it witnessed a sequential decline from ₹41.41 million in the preceding quarter. For the nine-month period ended December 2025, the company achieved a total income of ₹2,132.58 million and a net profit of ₹142.64 million. The results reflect steady operational performance in the zinc-based products segment despite rising expenses.
Key Highlights
Standalone Revenue from operations grew 16.7% YoY to ₹704.63 million in Q3 FY26.
Net Profit for the quarter stood at ₹37.56 million, showing a 6.2% YoY growth but a 9.3% QoQ decline.
Total expenses for the quarter increased to ₹690.11 million from ₹582.79 million in the year-ago period.
Nine-month (9M FY26) PAT reached ₹142.64 million, up from ₹136.60 million in 9M FY25.
Basic and Diluted EPS for the quarter was ₹0.96 (not annualized).
💼 Action for Investors
Investors should note the steady top-line growth but monitor margin pressure as profit growth is lagging behind revenue. The company's stable nine-month performance suggests it is maintaining its market position in the zinc oxide segment.